Estimating the impact of direct acting antiviral therapy on the prevalence of hepatitis C virus infection using phylogenetics

Introduction: Australia has provided unrestricted subsidized access to direct-acting antiviral (DAA) treatment for hepatitis C virus (HCV) infection since 2016. Epidemiological surveillance estimates suggest prevalence of chronic HCV infection has declined since 2016, but these estimates are not sep...

詳細記述

書誌詳細

主要な著者:	Hossain M.S. Sazzad, Hui Li, Behzad Hajarizadeh, Bethany A. Horsburgh, Jason Grebely, Gregory J. Dore, Rowena A. Bull, Andrew R. Lloyd, Chaturaka Rodrigo
フォーマット:	Artigo
言語:	Inglês
出版事項:	Elsevier 2025-05-01
シリーズ:	Virus Research
主題:	Hepatitis C virus Bayesian evolutionary analysis People who inject drugs Australia Prisons
オンライン･アクセス:	http://www.sciencedirect.com/science/article/pii/S0168170225000437
タグ:	タグ追加 タグなし, このレコードへの初めてのタグを付けませんか!